QSS
ESPR

Quantitative Systematic Strategies’s Esperion Therapeutics ESPR Stock Holding History

Quantitative Systematic Strategies’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-14,772
Closed -$579K – 436
2014
Q4 		$579K Buy
+14,772
New +$452K 0.23% 145

Other funds holding ESPR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Quantitative Systematic Strategies's ESPR Position: Q1 2015 in Review

Quantitative Systematic Strategies sold out of Esperion Therapeutics (ESPR) in Q1 2015, closing a stake of 14,772 shares — an estimated $579K sold.

Quantitative Systematic Strategies first reported a position in ESPR in Q4 2014 and held it in 1 quarter. The position peaked at $579K in Q4 2014. 141 funds tracked by Wall St. Rank hold ESPR as of Q1 2015.

  • Quantitative Systematic Strategies reported no remaining Esperion Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 14,772 Esperion Therapeutics shares in Q1 2015, an estimated $579K.
  • Quantitative Systematic Strategies first reported a position in Esperion Therapeutics in Q4 2014 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Esperion Therapeutics position peaked at $579K in Q4 2014.
  • 141 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q1 2015.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2015, filed 9 Apr 2015.